May 18, 2020 / 08:40PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Greetings. This is Dan Brennan. I cover tools, diagnostics and pharma services here for UBS.
Glad to be joined with the management team of Invitae: Sean George, CEO; Shelly Guyer, CFO; Laura D'Angelo Head of IR, very pleased you're with us today. Invitae has also been a key anchor tenant at the Genomics 2.0 conference that's held every August. So really thank them for their participation here.
Really looking forward to a good discussion. Feel free to anyone on the phone -- or excuse me, on the webcast, that is, to post a question up on the web. And I'm kind of happy to look at it and kind of get that into the live discussion that we're going to have here.
So Sean, Shelly, and Laura, thank you for joining, and welcome.
Sean E. George - Invitae Corporation - Co-Founder, President, CEO & Chairman
Yes. Thanks, Dan. Thanks for having us.
Daniel Gregory Brennan - UBS Investment Bank,
Invitae Corp at UBS Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot